List of Tables
    Table 1. Ornithine-Transcarbamylase Deficiency CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Ornithine-Transcarbamylase Deficiency Market Trends
    Table 3. Ornithine-Transcarbamylase Deficiency Market Drivers
    Table 4. Ornithine-Transcarbamylase Deficiency Market Challenges
    Table 5. Ornithine-Transcarbamylase Deficiency Market Restraints
    Table 6. Global Ornithine-Transcarbamylase Deficiency Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Ornithine-Transcarbamylase Deficiency Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Ornithine-Transcarbamylase Deficiency Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Ornithine-Transcarbamylase Deficiency Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Ornithine-Transcarbamylase Deficiency Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Ornithine-Transcarbamylase Deficiency Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Ornithine-Transcarbamylase Deficiency Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Ornithine-Transcarbamylase Deficiency Sales by Manufacturer, (K Pcs), 2017-2022
    Table 14. Global Ornithine-Transcarbamylase Deficiency Sales Share by Manufacturer, 2017-2022
    Table 15. Global Ornithine-Transcarbamylase Deficiency Price by Manufacturer (2017-2022) & (USD/Pcs)
    Table 16. Global Ornithine-Transcarbamylase Deficiency Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Ornithine-Transcarbamylase Deficiency by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ornithine-Transcarbamylase Deficiency as of 2021)
    Table 18. Top Players of Ornithine-Transcarbamylase Deficiency in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Ornithine-Transcarbamylase Deficiency Product Type
    Table 20. Date of International Manufacturers Enter into Ornithine-Transcarbamylase Deficiency Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Ornithine-Transcarbamylase Deficiency Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Ornithine-Transcarbamylase Deficiency Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Ornithine-Transcarbamylase Deficiency Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Ornithine-Transcarbamylase Deficiency Sales by Players, (K Pcs), 2020, 2021 & 2022
    Table 26. United States Ornithine-Transcarbamylase Deficiency Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Ornithine-Transcarbamylase Deficiency Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Ornithine-Transcarbamylase Deficiency Sales in Volume by Region (2017-2022) & (K Pcs)
    Table 29. Global Ornithine-Transcarbamylase Deficiency Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
    Table 30. Global Ornithine-Transcarbamylase Deficiency Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Ornithine-Transcarbamylase Deficiency Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Ornithine-Transcarbamylase Deficiency Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 33. North America Ornithine-Transcarbamylase Deficiency Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Ornithine-Transcarbamylase Deficiency Sales in Volume by Region (2017-2028) & (K Pcs)
    Table 35. Asia Pacific Ornithine-Transcarbamylase Deficiency Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Ornithine-Transcarbamylase Deficiency Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 37. Europe Ornithine-Transcarbamylase Deficiency Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Ornithine-Transcarbamylase Deficiency Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 39. Latin Americaa Ornithine-Transcarbamylase Deficiency Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Ornithine-Transcarbamylase Deficiency Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 41. Middle East and Africa Ornithine-Transcarbamylase Deficiency Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Lucane Pharma SA Corporation Information
    Table 43. Lucane Pharma SA Description and Business Overview
    Table 44. Lucane Pharma SA Ornithine-Transcarbamylase Deficiency Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 45. Lucane Pharma SA Ornithine-Transcarbamylase Deficiency Product
    Table 46. Lucane Pharma SA Recent Development
    Table 47. PhaseRx Inc Corporation Information
    Table 48. PhaseRx Inc Description and Business Overview
    Table 49. PhaseRx Inc Ornithine-Transcarbamylase Deficiency Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 50. PhaseRx Inc Product
    Table 51. PhaseRx Inc Recent Development
    Table 52. Promethera Biosciences SA Corporation Information
    Table 53. Promethera Biosciences SA Description and Business Overview
    Table 54. Promethera Biosciences SA Ornithine-Transcarbamylase Deficiency Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 55. Promethera Biosciences SA Product
    Table 56. Promethera Biosciences SA Recent Development
    Table 57. Selecta Biosciences Inc Corporation Information
    Table 58. Selecta Biosciences Inc Description and Business Overview
    Table 59. Selecta Biosciences Inc Ornithine-Transcarbamylase Deficiency Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 60. Selecta Biosciences Inc Product
    Table 61. Selecta Biosciences Inc Recent Development
    Table 62. Translate Bio Inc Corporation Information
    Table 63. Translate Bio Inc Description and Business Overview
    Table 64. Translate Bio Inc Ornithine-Transcarbamylase Deficiency Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 65. Translate Bio Inc Product
    Table 66. Translate Bio Inc Recent Development
    Table 67. Ultragenyx Pharmaceutical Inc Corporation Information
    Table 68. Ultragenyx Pharmaceutical Inc Description and Business Overview
    Table 69. Ultragenyx Pharmaceutical Inc Ornithine-Transcarbamylase Deficiency Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 70. Ultragenyx Pharmaceutical Inc Product
    Table 71. Ultragenyx Pharmaceutical Inc Recent Development
    Table 72. Unicyte AG Corporation Information
    Table 73. Unicyte AG Description and Business Overview
    Table 74. Unicyte AG Ornithine-Transcarbamylase Deficiency Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 75. Unicyte AG Product
    Table 76. Unicyte AG Recent Development
    Table 77. Key Raw Materials Lists
    Table 78. Raw Materials Key Suppliers Lists
    Table 79. Ornithine-Transcarbamylase Deficiency Customers List
    Table 80. Ornithine-Transcarbamylase Deficiency Distributors List
    Table 81. Research Programs/Design for This Report
    Table 82. Key Data Information from Secondary Sources
    Table 83. Key Data Information from Primary Sources
List of Figures
    Figure 1. Ornithine-Transcarbamylase Deficiency Product Picture
    Figure 2. Global Ornithine-Transcarbamylase Deficiency Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Ornithine-Transcarbamylase Deficiency Market Size 2017-2028 (US$ Million)
    Figure 4. Global Ornithine-Transcarbamylase Deficiency Sales 2017-2028 (K Pcs)
    Figure 5. United States Ornithine-Transcarbamylase Deficiency Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Ornithine-Transcarbamylase Deficiency Market Size 2017-2028 (US$ Million)
    Figure 7. United States Ornithine-Transcarbamylase Deficiency Sales 2017-2028 (K Pcs)
    Figure 8. United States Ornithine-Transcarbamylase Deficiency Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Ornithine-Transcarbamylase Deficiency Market Share in Global, in Volume (K Pcs) 2017-2028
    Figure 10. Ornithine-Transcarbamylase Deficiency Report Years Considered
    Figure 11. Product Picture of DTX-301
    Figure 12. Product Picture of SEL-313
    Figure 13. Product Picture of SHP-641
    Figure 14. Product Picture of PRX-OTC
    Figure 15. Product Picture of Others
    Figure 16. Global Ornithine-Transcarbamylase Deficiency Market Share by Type in 2022 & 2028
    Figure 17. Global Ornithine-Transcarbamylase Deficiency Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 18. Global Ornithine-Transcarbamylase Deficiency Sales Market Share in Value by Type (2017-2028)
    Figure 19. Global Ornithine-Transcarbamylase Deficiency Sales by Type (2017-2028) & (K Pcs)
    Figure 20. Global Ornithine-Transcarbamylase Deficiency Sales Market Share in Volume by Type (2017-2028)
    Figure 21. Global Ornithine-Transcarbamylase Deficiency Price by Type (2017-2028) & (USD/Pcs)
    Figure 22. United States Ornithine-Transcarbamylase Deficiency Market Share by Type in 2022 & 2028
    Figure 23. United States Ornithine-Transcarbamylase Deficiency Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 24. United States Ornithine-Transcarbamylase Deficiency Sales Market Share in Value by Type (2017-2028)
    Figure 25. United States Ornithine-Transcarbamylase Deficiency Sales by Type (2017-2028) & (K Pcs)
    Figure 26. United States Ornithine-Transcarbamylase Deficiency Sales Market Share in Volume by Type (2017-2028)
    Figure 27. United States Ornithine-Transcarbamylase Deficiency Price by Type (2017-2028) & (USD/Pcs)
    Figure 28. Product Picture of Hospital
    Figure 29. Product Picture of Clinic
    Figure 30. Product Picture of Others
    Figure 31. Global Ornithine-Transcarbamylase Deficiency Market Share by Application in 2022 & 2028
    Figure 32. Global Ornithine-Transcarbamylase Deficiency Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 33. Global Ornithine-Transcarbamylase Deficiency Sales Market Share in Value by Application (2017-2028)
    Figure 34. Global Ornithine-Transcarbamylase Deficiency Sales by Application (2017-2028) & (K Pcs)
    Figure 35. Global Ornithine-Transcarbamylase Deficiency Sales Market Share in Volume by Application (2017-2028)
    Figure 36. Global Ornithine-Transcarbamylase Deficiency Price by Application (2017-2028) & (USD/Pcs)
    Figure 37. United States Ornithine-Transcarbamylase Deficiency Market Share by Application in 2022 & 2028
    Figure 38. United States Ornithine-Transcarbamylase Deficiency Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 39. United States Ornithine-Transcarbamylase Deficiency Sales Market Share in Value by Application (2017-2028)
    Figure 40. United States Ornithine-Transcarbamylase Deficiency Sales by Application (2017-2028) & (K Pcs)
    Figure 41. United States Ornithine-Transcarbamylase Deficiency Sales Market Share in Volume by Application (2017-2028)
    Figure 42. United States Ornithine-Transcarbamylase Deficiency Price by Application (2017-2028) & (USD/Pcs)
    Figure 43. North America Ornithine-Transcarbamylase Deficiency Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 44. North America Ornithine-Transcarbamylase Deficiency Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 45. U.S. Ornithine-Transcarbamylase Deficiency Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Canada Ornithine-Transcarbamylase Deficiency Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Europe Ornithine-Transcarbamylase Deficiency Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 48. Europe Ornithine-Transcarbamylase Deficiency Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 49. Germany Ornithine-Transcarbamylase Deficiency Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. France Ornithine-Transcarbamylase Deficiency Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. U.K. Ornithine-Transcarbamylase Deficiency Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Italy Ornithine-Transcarbamylase Deficiency Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Russia Ornithine-Transcarbamylase Deficiency Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Asia-Pacific Ornithine-Transcarbamylase Deficiency Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 55. Asia-Pacific Ornithine-Transcarbamylase Deficiency Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 56. China Ornithine-Transcarbamylase Deficiency Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Japan Ornithine-Transcarbamylase Deficiency Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. South Korea Ornithine-Transcarbamylase Deficiency Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. India Ornithine-Transcarbamylase Deficiency Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Australia Ornithine-Transcarbamylase Deficiency Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Taiwan Ornithine-Transcarbamylase Deficiency Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Indonesia Ornithine-Transcarbamylase Deficiency Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Thailand Ornithine-Transcarbamylase Deficiency Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Malaysia Ornithine-Transcarbamylase Deficiency Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Philippines Ornithine-Transcarbamylase Deficiency Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Latin America Ornithine-Transcarbamylase Deficiency Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 67. Latin America Ornithine-Transcarbamylase Deficiency Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 68. Mexico Ornithine-Transcarbamylase Deficiency Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Brazil Ornithine-Transcarbamylase Deficiency Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Argentina Ornithine-Transcarbamylase Deficiency Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Middle East & Africa Ornithine-Transcarbamylase Deficiency Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 72. Middle East & Africa Ornithine-Transcarbamylase Deficiency Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 73. Turkey Ornithine-Transcarbamylase Deficiency Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Saudi Arabia Ornithine-Transcarbamylase Deficiency Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. U.A.E Ornithine-Transcarbamylase Deficiency Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 76. Ornithine-Transcarbamylase Deficiency Value Chain
    Figure 77. Ornithine-Transcarbamylase Deficiency Production Process
    Figure 78. Channels of Distribution
    Figure 79. Distributors Profiles
    Figure 80. Bottom-up and Top-down Approaches for This Report
    Figure 81. Data Triangulation
    Figure 82. Key Executives Interviewed